PTG-100

N/A

Report date: 2022/08/22 10:57:04
NME

Base Information

Drug NamePTG-100
Drug Alias NamePTG-100
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionIntegrin alpha-4/beta-7 antagonists
TargetsIntegrin alpha-4/beta-7
Therapy Area/IndicationsCeliac DiseaseColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBosnia and Herzegovina +[17] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesProtagonist Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesProtagonist Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCeliac Disease
Inactive IndicationsColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksN/A